Ikarian Capital, LLC Portfolio Holdings

Ikarian Capital, LLC

  • $328 Million
  • Q2 2025

Ikarian Capital, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $328 Million distributed in 133 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Alnylam Pharmaceuticals, Inc. with a value of $18.5M, Insmed Inc with a value of $16.5M, Verona Pharma PLC with a value of $13.9M, Crinetics Pharmaceuticals, Inc. with a value of $12.5M, and Akero Therapeutics, Inc. with a value of $11.7M.

Examining the 13F form we can see an decrease of $386M in the current position value, from $714M to 328M.

Ikarian Capital, LLC is based out at Dallas, TX

Below you can find more details about Ikarian Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $328 Million
Healthcare: $327 Million
ETFs: $728,000

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$56.1B
$18.5 Million 5.63% of portfolio
56,594
Q2 2025 Added 79.13%
$25.7B
$16.5 Million 5.03% of portfolio
163,751
Q2 2025 Added 93.1%
$6.52B
$13.9 Million 4.24% of portfolio
146,831
Q2 2025 Added 12.95%
$2.34B
$12.5 Million 3.81% of portfolio
433,431
Q2 2025 Reduced 17.19%
$2.52B
$11.7 Million 3.58% of portfolio
220,000
Q2 2025 Reduced 10.2%
$2.69B
$9.92 Million 3.03% of portfolio
305,000
Q2 2025 Added 52.5%
$1.88B
$7.96 Million 2.43% of portfolio
196,536
Q2 2025 Reduced 59.48%
$5.99B
$7.71 Million 2.35% of portfolio
233,464
Q2 2025 Added 55.66%
$2.1B
$7.68 Million 2.34% of portfolio
449,087
Q2 2025 Added 165.6%
$4.94B
$7.56 Million 2.31% of portfolio
209,938
Q2 2025 Reduced 0.06%
$1.07B
$7.44 Million 2.27% of portfolio
1,035,528
Q2 2025 New
$949M
$6.57 Million 2.01% of portfolio
469,949
Q2 2025 Reduced 5.05%
$540M
$6.26 Million 1.91% of portfolio
850,000
Q2 2025 Added 269.73%
$791M
$5.38 Million 1.64% of portfolio
1,068,062
Q1 2025 Added 18.96%
$257M
$5.07 Million 1.55% of portfolio
873,568
Q2 2025 New
$2.16B
$4.55 Million 1.39% of portfolio
209,649
Q2 2025 Reduced 16.02%
$8.63B
$4.24 Million 1.3% of portfolio
40,000
Q2 2025 New
$71.3M
$3.84 Million 1.17% of portfolio
1,099,700
Q2 2025 Reduced 0.03%
$1.17B
$3.46 Million 1.06% of portfolio
363,837
Q2 2025 Added 1.39%
$1.19B
$3 Million 0.91% of portfolio
129,691
Q1 2025 Added 73.64%
$460M
$2.95 Million 0.9% of portfolio
428,521
Q2 2025 Added 114.16%
$59.4M
$2.71 Million 0.83% of portfolio
1,000,221
Q2 2025 Reduced 2.44%
$22.2B
$2.7 Million 0.82% of portfolio
21,516
Q2 2025 New
$2.91B
$2.65 Million 0.81% of portfolio
100,000
Q2 2025 Added 100.0%
$858M
$2.57 Million 0.78% of portfolio
743,308
Q1 2025 Added 7.21%
$256M
$2.28 Million 0.69% of portfolio
175,000
Q1 2025 Reduced 12.5%
$468M
$2.26 Million 0.69% of portfolio
1,600,000
Q2 2025 Added 966.67%
$275M
$2.25 Million 0.69% of portfolio
198,528
Q2 2025 New
$1.03B
$2.24 Million 0.68% of portfolio
599,534
Q2 2025 Reduced 7.7%
$476M
$2.07 Million 0.63% of portfolio
967,590
Q2 2025 Reduced 20.53%
$43.8M
$2 Million 0.61% of portfolio
595,932
Q2 2025 Reduced 19.47%
$191M
$1.77 Million 0.54% of portfolio
868,069
Q2 2025 New
$1.51B
$1.74 Million 0.53% of portfolio
49,179
Q2 2025 Reduced 79.86%
$3.17B
$1.67 Million 0.51% of portfolio
119,986
Q2 2025 New
$1.42B
$1.33 Million 0.41% of portfolio
163,363
Q1 2025 Reduced 56.82%
$2.36B
$1.3 Million 0.4% of portfolio
75,000
Q1 2025 Added 1,986.81%
$125M
$1.26 Million 0.38% of portfolio
900,000
Q2 2025 Reduced 5.26%
$1.12B
$1.21 Million 0.37% of portfolio
619,258
Q1 2025 Added 642.45%
$765M
$1.05 Million 0.32% of portfolio
161,137
Q2 2025 New
$241M
$826,000 0.25% of portfolio
1,425,239
Q1 2025 Added 50.78%
$0
$728,000 0.22% of portfolio
5,755
Q2 2025 New
$89.2M
$680,000 0.21% of portfolio
1,260,179
Q2 2025 Reduced 32.25%
$23.8M
$639,000 0.2% of portfolio
914,170
Q1 2025 Reduced 43.37%
$63.7M
$556,000 0.17% of portfolio
705,010
Q2 2025 New
$796M
$332,000 0.1% of portfolio
14,096
Q2 2025 New
$87.5M
$308,000 0.09% of portfolio
265,769
Q4 2024 Reduced 0.25%
$35M
$247,000 0.08% of portfolio
213,052
Q4 2024 Reduced 0.16%
$794M
$265,000 0.08% of portfolio
49,396
Q2 2025 New
$228M
$249,000 0.08% of portfolio
31,360
Q2 2025 Reduced 87.46%

Summary

  • Portfolio
  • No. of Stocks 133
  • Current Value $328 Million
  • Prior Value $714 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 24 stocks
  • Additional Purchases 14 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 28 stocks
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email